Correction studies with factor deficient plasma
Contribution of fibrin stabilization to clot strength Supplementation of factor XIII deficient plasma with the purified zymogen
7
Studies on the purification of antihemophilic factor (factor VIII): II Separation of partially purified antihemophilic factor by gel filtration of plasma
7
STUDIES ON THE ACTION OF HAGEMAN FACTOR: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IN TURN ACTIVATES PLASMA THROMBOPLASTIN ANTECEDENT
18
STUDIES ON THE ACTION OF HAGEMAN FACTOR: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IN TURN ACTIVATES PLASMA THROMBOPLASTIN ANTECEDENT
Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENT
10
Stabilization of Factor VIII in Plasma by the von Willebrand Factor: STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE
16
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H–deficient mice
12
The Binding and Cleavage Characteristics of Human Hageman Factor during Contact Activation: A COMPARISON OF NORMAL PLASMA WITH PLASMAS DEFICIENT IN FACTOR XI, PREKALLIKREIN, OR HIGH MOLECULAR WEIGHT KININOGEN
10
Factor XIII in human plasma and platelets
8
Plasma Focus Studies in Serbia
7
Experimental studies of a helicon plasma
190
Immunochemical Studies of Plasma Kallikrein
12
Power Factor Correction
27
POWER FACTOR CORRECTION
8
Carbohydrate Ratio Correction Target Correction Factor
20
Volume Correction Factor Development
29
Power Factor Correction For Residential
24
Automatic Power Factor Correction
24
AT LOAD POWER FACTOR CORRECTION
86
HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA
9